The Drug Delivery Devices Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global drug delivery devices market is expected to grow from $1.4 billion in 2019 to about $1.6 billion in 2020 as there is a marginal increase in demand due to the use of such devices in the treatment of Covid-19 patients. The market is expected to stabilize and reach $1.9 billion at a CAGR of 8.2% through 2023.
Make an Inquiry about this report:
https://bit.ly/2WB41OF
The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Drug Delivery Devices Market: F. Hoffmann-La Roche Ltd; 3M Company; Pfizer Inc.; Baxter International and others.
Industry News:
May 4, 2020: Kindeva Drug Delivery recently announced that it launched as an independent company, shedding its former 3M Drug Delivery Systems name. The formation of the independent company follows its acquisition by Altaris Capital Partners in a transaction that was worth $650 million. Through the acquisition, 3M will hold a 17% minority interest in Kindeva with Altaris. Kindeva is a contract development and manufacturing company for the pharmaceutical industry. It has developed and manufactured therapies to treat debilitating and chronic diseases, according to the company. It microneedle-based drug delivery platforms are being used in a number of development programs that include osteoporosis, immunotherapies, COVID-19 vaccines and other difficult to deliver therapies.
August 10, 2018: At the start of the week, New Jersey-based Antares Pharma announced that it would be using its proprietary QuickShot auto-injector technology to develop a drug device rescue pen alongside US pharmaceutical giant Pfizer. However, Antares and Pfizer are keeping details of the deal close to the chest, only revealing that the combination device would be used to administer “an undisclosed Pfizer drug.”
What’s a bit clearer, however, are the bones of the collaboration which will see Pfizer bankrolling development of the product and taking full responsibility for getting US Food and Drug Administration (FDA) approval for the combination drug device. While a supply and commercialization agreement between the two pharma companies has yet to be inked, Antares disclosed that they would likely provide Pfizer with the packaged product at cost plus margin, and Pfizer would sell the drug within the US. Antares would also likely collect royalties on sales of the drug device combination product, allowing them to cover manufacturing costs without having to invest anything into commercialization.
Market Overview:
Drug delivery devices, specifically respiratory-based delivery devices, are estimated to gain demand owing to the Covid-19 pandemic. Drugs used for Covid-19 treatment are both oral and injectable; however, a marginal increase is expected for pulmonary or respiratory-based drug delivery devices.
The drug delivery devices market consists of the sales of medical devices and equipment that are used for delivering specific drugs to a specific part of the body to cure chronic diseases such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases. The market includes the sales of the devices that are specifically made for delivering the specific drugs according to the various administration techniques such as oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery. Drug delivery devices used in various patient care settings such as hospitals, diagnostic centers, pharmaceutical companies, clinics and home care settings are included in this market. The drug delivery devices market in Asia Pacific is forecasted to register the highest CAGR during 2019-2023.
The regulatory changes related to medical devices is expected to restraint the growth of drug delivery devices market. The companies operating in the market are required to adapt according to the changes in the regulatory framework, which may limit business at the bottom line. Also, companies will have to bear the heavy cost of adapting to the changing regulatory framework. Also, the sudden changes in the regulatory framework related to medical devices can result in losses, fines, penalties at a global level. For instance, European Union (EU) and the parliament in 2017 approved the new Medical Device Regulation (MDR) and Medical Device Single Audit Program (MDSAP) to monitor all the medical devices for quality. The new MDSAP will come into effect from 2020 and is adopted by regulators in the US, Canada, Japan, Brazil, and Australia. Following the changes, in Canada, all the medical device manufacturers including drug delivery products manufacturers, will have to comply with the requirements of MDSAP and are required to submit the MDSAP reports to the regulatory body in order to obtain or maintain the device licenses, resulting in high costs and time loss. Thus, the growth of the drug delivery devices market is limited by the regulatory changes related to medical devices.
The microneedle (MN), is a highly efficient and versatile medical device technology, due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety. The major players operating in the global microneedle drug delivery system include, 3M, Vetter Pharma International GmbH, nanoBioSciences LLC, NanoPass and more. The microneedles are fabricated using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles. Once, the microneedles dissolve in the skin, the drug gets released. This novel delivery method allows a wider variety of molecules to pass the skin’s barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.
The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market. According to the world health organization (WHO), by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. There are various routes of drug administration for medical drugs. The selection of the route depends on three factors – the effect desired; the type of the disease and the type of the product. Currently, the development of new drug delivery systems plays a major role in pharmaceutical industries. Research and development (R&D) in drug delivery is increasing throughout the world due to increasing prevalence of these diseases. Most of the pharmaceutical companies are focusing on multiple drug delivery technologies for creating excellent advantages and better outcome for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.
In September 2018, Sulzer Ltd., a Swiss-based industrial engineering company specialized in pumping, agitation, mixing, separation and application technologies for all fluid types, acquired Medmix Systems AG for an undisclosed amount. Through this acquisition, Sulzer Ltd. aims towards broadening its business segment in the healthcare division by utilizing the product portfolio offered by Medmix System. Medmix Systems AG is a Switzerland-based manufacturer of medical equipment & devices, that specializes in providing applicators for drug delivery, bone repair, oral surgery in the healthcare industry.
Companies in the drug delivery devices market are collaborating with other companies within the industry in order to strengthen their product portfolio as well as to expand their footprint across different geographies. For instance, in July 2018, Gerresheimer AG, a Germany based provider of pharmaceutical packaging and drug delivery devices, acquired Sensile Medical AG for $413.4 million. The acquisition helped Gerresheimer AG in broadening its technological portfolio by enabling them to offer drug delivery devices for pharmaceutical and biopharmaceutical customers. Sensile Medical AG is a Switzerland based manufacturer of liquid drug delivery devices.
Browse in-depth and report summary TOC on “Drug Delivery Devices” Market:
https://bit.ly/3clxenG
Regional Analysis For Drug Delivery Devices Market:
For comprehensive understanding of market dynamics, the global Drug Delivery Devices market is analyzed across key geographies namely:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Drug Delivery Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2020–2023.
Following are major Table of Content of Drug Delivery Devices Market:
– Global Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
– Global Market competition by top Players
– Analysis by Regions
– Consumption by Regions
– Consumption, By Types, Revenue and Market share by Types
– Consumption, By Applications, Market share (%) and Growth Rate by Applications
– Complete profiling and analysis of Players
– Industrial Chain, Sourcing Strategy and Downstream Buyers
– Marketing Strategy Analysis, Distributors/Traders
– Global Market Effect Factors Analysis
– Global Market Forecast
– Global Market Research Findings and Conclusion, Appendix, methodology and data source
Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects. The report supplies the international economic competition with the assistance of Porter’s Five Forces Analysis and SWOT Analysis.
We Offer Customization On Report Based On Specific Client Requirement:
– Free country Level analysis for any 5 countries of your choice.
– Free Competitive analysis of any 5 key market players.
– Free 40 analyst hours to cover any other data point.
How we have factored the effect of Covid-19 in our report:
All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.
ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
CONTACT US:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com